• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Involvement of a co-factor of Notch signaling, Mastermind, into Schizophrenia

Research Project

Project/Area Number 24659143
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeSingle-year Grants
Research Field Pathological medical chemistry
Research InstitutionChiba University

Principal Investigator

KITAGAWA Motoo  千葉大学, 医学(系)研究科(研究院), 准教授 (40262026)

Co-Investigator(Kenkyū-buntansha) TANIGAKI Kenji  滋賀県立成人病センター, 研究員 (70362473)
Co-Investigator(Renkei-kenkyūsha) HASHIMOTO Kenji  千葉大学, 社会精神保健教育研究センター, 教授 (10189483)
Project Period (FY) 2012-04-01 – 2014-03-31
Project Status Completed (Fiscal Year 2013)
Budget Amount *help
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2013: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2012: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
KeywordsNotchシグナル / 統合失調症 / Mastermind
Research Abstract

During Notch signaling, ligand stimulation induces generation of Notch intracellular domain, which is subsequently transported to the nuclei. With a DNA-binding protein RBP-J and a transcriptional co-activator Mastermind (Mam), the Notch intracellular domain forms a trimeric complex that activates transcription from the target promoters. We had found that heterozygous knockout mice of one of Mam genes, MamL1, exhibit increased sensitivity to dopamine, mimicking a part of symptoms of schizophrenia in humans. We have found heterozygous knockout mice of Rbp-j also exhibit very similar phenotype. Furthermore, by examining blood-derived genomic DNA from schizophrenic patients and healthy controls, we have found schizophrenia-specific missense polymorphisms in coding regions of both RBP-J and MAML1 genes. We are examining effects of these polymorphisms on the functions of these proteins.

Report

(3 results)
  • 2013 Annual Research Report   Final Research Report ( PDF )
  • 2012 Research-status Report
  • Research Products

    (53 results)

All 2014 2013 2012 2011 Other

All Journal Article (47 results) (of which Peer Reviewed: 47 results) Presentation (6 results)

  • [Journal Article] A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis2014

    • Author(s)
      Kimura H., Kanahara N., Komatsu N., Ishige M., Muneoka K., Yoshimura M., Yamanaka H., Suzuki T., Komatsu H., Sasaki T., Hashimoto T., Hasegawa T., Shiina A., Ishikawa M., Sekine Y., Shiraishi T., Watanabe H., Shimizu E., Hashimoto K., Iyo M
    • Journal Title

      Schizophrenia Res.

      Volume: 155 Issue: 1-3 Pages: 52-58

    • DOI

      10.1016/j.schres.2014.02.022

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] R-Stereoisomer of ketamine as alternative of ketamine for treatment-resistant major depression2014

    • Author(s)
      Hashimoto K
    • Journal Title

      Clin. Psychopharmacol. Neurosci.

      Volume: 12 Issue: 1 Pages: 72-73

    • DOI

      10.9758/cpn.2014.12.1.72

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Effects of Brilliant Blue G on Serum Tumor Necrosis Factor-αLevels and Depression-like Behavior in Mice after Lipopolysaccharide Administration2014

    • Author(s)
      Ma M., Ren Q., Zhang J.C., Hashimoto K
    • Journal Title

      Clin. Psychopharmacol. Neurosci.

      Volume: 12 Issue: 1 Pages: 31-36

    • DOI

      10.9758/cpn.2014.12.1.31

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells2014

    • Author(s)
      Ishima T., Fujita Y., Hashimoto K
    • Journal Title

      Eur. J. Pharmacol.

      Volume: 727 Pages: 167-173

    • DOI

      10.1016/j.ejphar.2014.01.064

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] A positive correlation between serum levels of mature brain-derived neurotrophic factor and negative symptoms in schizophrenia2014

    • Author(s)
      Niitsu T., Ishima T., Yoshida T., Hashimoto T., Matsuzawa D., Shirayama Y., Nakazato M., Shimizu E., Hashimoto K., and Iyo M
    • Journal Title

      Psychiatry Res.

      Volume: 215 Issue: 2 Pages: 268-273

    • DOI

      10.1016/j.psychres.2013.12.009

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Tipepidine in children with Attention-Deficit/Hyperactivity Disorder : A 4-week, open-label, preliminary study2014

    • Author(s)
      Sasaki T., Hashimoto K., Tachibana M., Kurata T., Okawada K., Ishikawa M., Kimura H., Komatsu H., Ishikawa M., Hasegawa T., Shiina A., Hashimoto T., Kanahara N., Shiraishi T., Iyo M
    • Journal Title

      preliminary study. Neuropsychiatrc. Dis. Treatment

      Volume: 10 Pages: 147-151

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Role of the NMDA receptor in cognitive deficits, anxiety, and depressive-like behavior in juvenile and adult mice after neonatal dexamethasone exposure.2014

    • Author(s)
      Li SX et al.
    • Journal Title

      Neurobiology of Disease

      Volume: 62 Pages: 124-134

    • DOI

      10.1016/j.nbd.2013.09.004

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] 7,8-Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine2014

    • Author(s)
      Ren Q., Zhang J.C., Ma M., Fujita Y., Wu J., Hashimoto K
    • Journal Title

      Psychopharmacology

      Volume: 231 Issue: 1 Pages: 159-166

    • DOI

      10.1007/s00213-013-3221-7

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] R (-)-Ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine.2014

    • Author(s)
      Zhang JC et al.
    • Journal Title

      Pharmacol. Biochem. Behav.

      Volume: 116 Pages: 137-143

    • DOI

      10.1016/j.pbb.2013.11.033

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] MAML1 enhances the transcriptional activity of Runx2 and plays a role in bone development2013

    • Author(s)
      Watanabe T, Komori T, Asahara H (他10名)
    • Journal Title

      PLos Genet

      Volume: 9(1) Issue: 1 Pages: 1003132-1003132

    • DOI

      10.1371/journal.pgen.1003132

    • NAID

      120006985752

    • Related Report
      2013 Annual Research Report 2013 Final Research Report 2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] Deficits in microRNA-mediated Cxcr4/Cxcl12 signaling in neurodevelopmental deficits in a 22q11 deletion syndrome mouse model.2013

    • Author(s)
      Toritsuka M, Kimoto S, Muraki K, Landek-Salgado MA, Yoshida A, Yamamoto N, Horiuchi Y, Hiyama H, Tajinda K, Keni N, Illingworth E, Iwamoto T, Kishimoto T, Sawa A, Tanigaki K.
    • Journal Title

      Proc Natl Acad Sci U S A

      Volume: 110 Issue: 43 Pages: 17552-17557

    • DOI

      10.1073/pnas.1312661110

    • Related Report
      2013 Annual Research Report 2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Notch signaling regulates nucleocytoplasmic Olig2 translocation in reactive astrocytes differentiation after ischemic stroke2013

    • Author(s)
      Marumo T, Takagi Y, Muraki K, Hashimoto N, Miyamoto S, Tanigaki K.
    • Journal Title

      Neurosci Res

      Volume: 75(3) Issue: 3 Pages: 204-9

    • DOI

      10.1016/j.neures.2013.01.006

    • Related Report
      2013 Annual Research Report 2013 Final Research Report 2012 Research-status Report
    • Peer Reviewed
  • [Journal Article] Beneficial effects of sigma-1 agonist fluvoxamine for tardive dyskinesia and tardive akathisia in patients with schizophrenia : report of three cases2013

    • Author(s)
      Albayrak Y., Hashimoto K
    • Journal Title

      Psychiatry Investigation

      Volume: 10 Issue: 4 Pages: 417-420

    • DOI

      10.4306/pi.2013.10.4.417

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine, but not quetiapine2013

    • Author(s)
      Ünsal C., Albayrak Y., Albayrak N., Kuloğlu M., Hashimoto K
    • Journal Title

      Neuropsychiatrc Dis. Treatment

      Volume: 9 Pages: 1545-1552

    • DOI

      10.2147/ndt.s52463

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Low Openness on the Revised NEO Personality Inventory as a Risk Factor for Treatment-Resistant Depression2013

    • Author(s)
      Takahashi M., Shirayama Y., Muneoka K., Suzuki M., Sato K., Hashimoto K
    • Journal Title

      PLoS ONE

      Volume: 8 Issue: 9 Pages: e71964-e71964

    • DOI

      10.1371/journal.pone.0071964

    • URL

      https://localhost/en/publications/6a5fb6bb-0f99-444a-81b4-5311895cb812

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Effects of AS2586114, soluble epoxide hydrolase inhibitor, on hyperlocomotion and prepulse inhibition deficits in mice after administration of phencyclidine2013

    • Author(s)
      Ma M., Ren Q., Fujita Y., Ishima T., Zhang J.C., Hashimoto K
    • Journal Title

      Pharmacol. Biochem. Behav.

      Volume: 110 Pages: 98-103

    • DOI

      10.1016/j.pbb.2013.06.005

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Personality Traits as Risk Factors for Treatment-Resistant Depression2013

    • Author(s)
      Takahashi M., Shirayama Y., Muneoka K., Suzuki M., Sato K., Hashimoto K
    • Journal Title

      PLoS ONE

      Volume: 8 Issue: 5 Pages: e63756-e63756

    • DOI

      10.1371/journal.pone.0063756

    • URL

      https://pure.teikyo.jp/en/publications/e92fb269-a5f6-453b-b74b-f3e4162f1c63

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Prenatal immune activation and subsequent peripubertal stress as a new model of schizophrenia2013

    • Author(s)
      Yoshimi N., Futamura T., Hashimoto K
    • Journal Title

      Expert Rev. Neurother.

      Volume: 13 Issue: 7 Pages: 747-750

    • DOI

      10.1586/14737175.2013.811191

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Longitudinal changes in serum brain-derived neurotrophic factor in accidient survivors with posttraumatic stress disorder2013

    • Author(s)
      Matsuoka Y., Nishi D., Noguchi H., Kim Y., Hashimoto K
    • Journal Title

      Neuropsychobiology

      Volume: 68 Issue: 1 Pages: 44-50

    • DOI

      10.1159/000350950

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Effects of TrkB agonist 7,8-dihydroxyflavone on sensory gating deficits in mice after administration of methamphetamine2013

    • Author(s)
      Ren Q., Zhang J.C., Fujita Y., Ma M., Wu J., Hashimoto K
    • Journal Title

      Pharmacol. Biochem. Behav.

      Volume: 106 Pages: 124-127

    • DOI

      10.1016/j.pbb.2013.03.016

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Neonatal disruption of serine racemase causes schizophrenia-like behavioral abnormalities in adulthood : Clinical rescue by D-serine2013

    • Author(s)
      Hagiwara H., Iyo M., Hashimoto K
    • Journal Title

      PLoS One

      Volume: 8 Issue: 4 Pages: e62438-e62438

    • DOI

      10.1371/journal.pone.0062438

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Old drug ifenprodil, new hope for PTSD with a history of childhood abuse.2013

    • Author(s)
      Hashimoto K. et al
    • Journal Title

      Psychopharmacology

      Volume: 227 Issue: 2 Pages: 375-376

    • DOI

      10.1007/s00213-013-3092-y

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Differential levels of brain amino acids in rat models presenting learned helplessness or non-learned helplessness2013

    • Author(s)
      Muneoka K., Shirayama Y., Horio M., Iyo M., Hashimoto K
    • Journal Title

      Psychopharmacology

      Volume: 229 Issue: 1 Pages: 63-71

    • DOI

      10.1007/s00213-013-3080-2

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders2013

    • Author(s)
      Hashimoto, K., Malchow, B., Falkai, P., and Schmitt, A
    • Journal Title

      Eur. Arch. Psychiatry Clin. Neurosci

      Volume: (in press) Issue: 5 Pages: 367-377

    • DOI

      10.1007/s00406-013-0399-y

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Ifenprodil for the treatment of flashbacks in adolescent female posttraumatic stress disorder patients with a history of abuse2013

    • Author(s)
      Sasaki T., Hashimoto K., Okawada K., Tone J., Machizawa A., Tano A., Nakazato M., Iyo M
    • Journal Title

      Psychother. Psychosom.

      Volume: 82 Issue: 5 Pages: 344-345

    • DOI

      10.1159/000348585

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Potential role of sigma-1 receptor chaperone in the beneficial effects of donepezil for dementia with Lewy bodies2013

    • Author(s)
      Hashimoto K
    • Journal Title

      Clin. Psychopharmacol. Neurosci.

      Volume: 11 Issue: 1 Pages: 43-44

    • DOI

      10.9758/cpn.2013.11.1.43

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Reply to : Acute stress symptoms do not worsen in PTSD and abuse with a single subanesthetic dose of ketamine2013

    • Author(s)
      Kishimoto A., Hashimoto K
    • Journal Title

      Biol. Psychiatry

      Volume: 73 Issue: 12 Pages: e39-e39

    • DOI

      10.1016/j.biopsych.2012.10.018

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Optimal extent of dopamine D_2 receptor occupancy by antipsychotics for treatment of dopamine supersensitivity psychosis and late-onset psychosis2013

    • Author(s)
      Iyo M., Tadokoro S., Kanahara N., Niitsu T., Watanabe H., Hashimoto K
    • Journal Title

      J. Clin. Psychopharmacol.

      Volume: 33 Issue: 3 Pages: 398-404

    • DOI

      10.1097/jcp.0b013e31828ea95c

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Is D-cycloserine a prodrug forD-serine in the brain? Biol2013

    • Author(s)
      Horio, M., Mori, H., and Hashimoto, K
    • Journal Title

      Psychiatry

      Volume: (in press) Issue: 12 Pages: e33-e34

    • DOI

      10.1016/j.biopsych.2012.07.013

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice2013

    • Author(s)
      Horio M., Fujita Y., Hashimoto K
    • Journal Title

      Fund. Clin. Pharmacol.

      Volume: 27 Issue: 5 Pages: 483-488

    • DOI

      10.1111/j.1472-8206.2012.01045.x

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Decreased levels of D-aspartic acid in the forebrain of serine racemase (Srr) knock-out mice2013

    • Author(s)
      Horio, M., Ishima, T., Fujita, Y., Inoue, R., Mori, H., and Hashimoto, K
    • Journal Title

      Neurochem. Int

      Volume: 62 Issue: 6 Pages: 843-847

    • DOI

      10.1016/j.neuint.2013.02.015

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice.2013

    • Author(s)
      Ma XC et al
    • Journal Title

      PLOS ONE

      Volume: 8 Issue: 2 Pages: e56053-e56053

    • DOI

      10.1371/journal.pone.0056053

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Effects of antidepressants on alterations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration.2013

    • Author(s)
      Ohgi Y. et al
    • Journal Title

      Pharmacol. Biochem. Behav.

      Volume: 103 Issue: 4 Pages: 853-859

    • DOI

      10.1016/j.pbb.2012.12.003

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Sigma-1 receptor chaperone and brain-derived neurotrophic factor : emerging links between cardiovascular disease and depression2013

    • Author(s)
      Hashimoto K
    • Journal Title

      Prog. Neurobiol.

      Volume: 100 Pages: 15-29

    • DOI

      10.1016/j.pneurobio.2012.09.001

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Beneficial effects of sigma-1 agonist fluvoxamine for tardive dyskinesia in patients with post-psychotic depression : report of five cases2012

    • Author(s)
      Albayrak Y., Hashimoto K
    • Journal Title

      Prim. Care Companion CNS Disorders

      Volume: 14

    • DOI

      10.4088/pcc.12br01401

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Neurite outgrowth mediated by the heat shock protein Hsp90α: a novel target for the antipsychotic drug aripiprazole.2012

    • Author(s)
      Tamaki Ishima
    • Journal Title

      Translational Psychiatry

      Volume: 2 Issue: 10 Pages: e170-e170

    • DOI

      10.1038/tp.2012.97

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder2012

    • Author(s)
      Yoshida T., Ishikawa M., Niitsu T., Nakazato M., Watanabe H., Shiraishi T., Shiina A., Hashimoto T., Kanahara N., Hasegawa T., Enohara M., Kimura H., Iyo M., Hashimoto K
    • Journal Title

      PLoS One

      Volume: 7 Issue: 8 Pages: e42676-e42676

    • DOI

      10.1371/journal.pone.0042676

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Effects of the antioxidant sulforaphane on hyperlocomotion and prepulse inhibition deficits in mice after administration of phencyclidine2012

    • Author(s)
      Shirai Y., Fujita Y., Hashimoto K
    • Journal Title

      Clin. Psychopharmacol. Neurosci.

      Volume: 10 Issue: 2 Pages: 94-98

    • DOI

      10.9758/cpn.2012.10.2.94

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] A randomized, double-blind, placebo-controlled trial of fluvoxamine in patients with schizophrenia : a preliminary study2012

    • Author(s)
      Niitsu T., Fujisaki M., Shiina A., Yoshida T., Hasegawa T., Kanahara N., Hashimoto T., Shiraishi T., Fukami G., Nakazato M., Shirayama Y., Hashimoto K., Iyo M
    • Journal Title

      J. Clin. Psychopharmacol.

      Volume: 32 Issue: 1 Pages: 593-601

    • DOI

      10.1186/1744-859x-9-27

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Protective effects of antioxidant sulforaphane on the behavioral changes and neurotoxicity in mice after administration of methamphetamine2012

    • Author(s)
      Chen H., Wu J., Zhang J., Fujita Y., Ishima T., Iyo M., Hashimoto K
    • Journal Title

      Psychopharmacology

      Volume: 222 Issue: 1 Pages: 37-45

    • DOI

      10.1007/s00213-011-2619-3

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Depressive-like behavior in adrenocorticotropic hormone-treated rats by blocked by memantine2012

    • Author(s)
      Tokita K., Fujita Y., Yamaji T., Hashimoto K
    • Journal Title

      Pharmacol. Biochem. Behav.

      Volume: 102 Issue: 2 Pages: 329-334

    • DOI

      10.1016/j.pbb.2012.05.007

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by ifenprodil: the role of sigma-1 and IP3 receptors.2012

    • Author(s)
      Tamaki Ishima
    • Journal Title

      PLoS One.

      Volume: 7(5) Issue: 5 Pages: e37989-e37989

    • DOI

      10.1371/journal.pone.0037989

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] In Vivo Evaluation of (11)C-labeled Three Radioligands for Glycine Transporter 1 in the Mouse Brain2012

    • Author(s)
      Zhang J.C., Toyohara J., Wu J., Ishiwata K., Hashimoto, K
    • Journal Title

      Clin Psychopharmacol Neurosci.

      Volume: 10 Issue: 1 Pages: 34-43

    • DOI

      10.9758/cpn.2012.10.1.34

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Possible involvement of brain-derived neurotrophic factor (BDNF) in eating disorders2012

    • Author(s)
      Nakazato M., Hashimoto K., Shimizu E., Niitsu T., Iyo M
    • Journal Title

      IUBMB Life

      Volume: 64 Issue: 5 Pages: 355-361

    • DOI

      10.1002/iub.1012

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Role of serine racemase in behavioral sensitization in mice after repeated administration of methamphetamine2012

    • Author(s)
      Horio M., Kohno M., Fujita Y., Ishima T, Inoue R, Mori H, Hashimoto K
    • Journal Title

      PLoS One

      Volume: 7

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] The antibiotic minocycline prevents methamphetamine-induced rewarding effects in mice2012

    • Author(s)
      Fujita Y., Kunitachi S., Iyo M., Hashimoto K
    • Journal Title

      Pharmacol. Biochem. Behav.

      Volume: 101 Issue: 2 Pages: 303-306

    • DOI

      10.1016/j.pbb.2012.01.005

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Chronic Treatment With Aripiprazole Prevents Development of Dopamine Supersensitivity and Potentially Supersensitivity Psychosis2011

    • Author(s)
      Tadokoro S, et al.
    • Journal Title

      Schizophr Bull

      Volume: 38 Issue: 5 Pages: 1-9

    • DOI

      10.1093/schbul/sbr006

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Presentation] Neuropathological analysis of 22q deletion syndrome model mice2013

    • Author(s)
      谷垣健二
    • Organizer
      第36回日本分子生物学会年会
    • Place of Presentation
      神戸市
    • Related Report
      2013 Final Research Report
  • [Presentation] Behavioral analysis of neuron-specific RBP-J knockout mice2013

    • Author(s)
      谷垣健二
    • Organizer
      The Notch Meeting VII
    • Place of Presentation
      ギリシャ共和国アテネ市
    • Related Report
      2013 Final Research Report
  • [Presentation] Behavioral Analysis of Neuron-specific RBP-J knockout mice.2013

    • Author(s)
      谷垣健二
    • Organizer
      Notch Meeting VII
    • Place of Presentation
      ギリシャ共和国アテネ市
    • Related Report
      2013 Annual Research Report
  • [Presentation] Neuropathological analysis of 22q11.2 deletion syndrome model mice.2013

    • Author(s)
      谷垣健二
    • Organizer
      第36回日本分子生物学会年会
    • Place of Presentation
      神戸市
    • Related Report
      2013 Annual Research Report
  • [Presentation] RBP-J conditional knockoutマウスの行動学的解析2012

    • Author(s)
      谷垣健二
    • Organizer
      第35回日本分子生物学会年会
    • Place of Presentation
      福岡市
    • Related Report
      2013 Final Research Report
  • [Presentation] RBP-J conditional knockout マウスの行動学的解析

    • Author(s)
      谷垣健二
    • Organizer
      第35回日本分子生物学会
    • Place of Presentation
      福岡国際会議場・マリンメッセ福岡
    • Related Report
      2012 Research-status Report

URL: 

Published: 2013-05-31   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi